46
FAECALIBACTERIUM PRAUSNITZII INHIBITS GASTRIC CANCER AND ANTAGONIZES HELICOBACTER PYLORI COLONIZATION
Date
May 18, 2024
Tracks
Related Products
THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
The gut microbiota is closely related to cancer patient response to immune checkpoint inhibitors (ICI). However, there are inconsistencies in species affecting ICI efficacy, whilst the role of non-bacterial microbes in immunotherapy remains elusive…
<i>LACTOBACILLUS ACIDOPHILUS </i>SUPPRESSES NON-ALCOHOLIC FATTY LIVER DISEASE-ASSOCIATED HEPATOCELLULAR CARCINOMA THROUGH PRODUCING METABOLITE VALERIC ACID
BACKGROUND: Through shotgun metagenomic sequencing, we identified the depletion of probiotic species_ Lactobacillus acidophilus_ in stools of mice with non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC)…
TARGETING SQLE REACTIVATES ANTITUMOR IMMUNITY AND RESCUES IMMUNE CHECKPOINT EFFICACY IN NON-ALCOHOLIC STEATOHEPATITIS-INDUCED HEPATOCELLULAR CARCINOMA
BACKGROUND: The LI-RADS (Liver Reporting and Data Systems) was created to standardize reporting of CT/MR imaging for liver masses in cirrhosis patients at risk of hepatocellular carcinoma (HCC)…
<i>PEPTOSTREPTOCOCCUS STOMATIS</i> PROMOTES COLORECTAL TUMORIGENESIS AND TYROSINE KINASE INHIBITOR RESISTANCE THROUGH ALTERNATIVE ACTIVATION OF ERBB2
BACKGROUND AND AIMS: Peptostreptococcus stomatis (_P. stomatis_) is an enriched bacterium in colorectal cancer (CRC) patients as compared to healthy subjects in multiple cohorts. However, the potential role of _P. stomatis_ in colorectal tumorigenesis remains obscure…